CEO Roundtable
Creative Private Finance Options for Development-Stage Companies
Thursday, October 20
3:30 p.m. - 4:30 p.m.
Telegraph Hill
A panel of life science investors and senior management from early biotech companies discussed private financing trends and creative funding options. The session covered the types of deals that are getting funded today and how companies outside of the mainstream can successfully attract capital. The panel reviewed funding strategies for early stage companies, and highlighted promising sources of capital including angel, venture and corporate.
Moderator:
- J. Casey McGlynn, Chairman, Life Sciences Group, Wilson Sonsini Goodrich & Rosati
Panelists:
- Michael Chang, CEO, Optimer Pharmaceuticals, Inc.
- Allan W. May, Chairman, Athenagen
- Jonathan J. MacQuitty, PhD, President, Abingworth Management, Inc.
- Craig C. Taylor, Partner, Alloy Ventures, Inc.